Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. ARYD.NASDAQ

ARYA Sciences Acquisition IV Corp (ARYD NASDAQ) stock market data APIs

$10.725 -0.05(-0.5%) as of July 26, 2024
Price chart is built with Anychart

Arya Sciences Acquisition Corp IV does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring North American or European companies in the life sciences and medical technology sectors. The company was incorporated in 2020 and is based in New York, New York.

ARYA Sciences Acquisition IV Corp Financial Data Overview

10.7712
10.725
-
10.79
10.55
10.55-11.57
80 490 K
3 799 K
0
-0.0316
-0.002
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ARYD',
Type: 'Common Stock',
Name: 'ARYA Sciences Acquisition IV Corp',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00Z73NMR5',
ISIN: 'KYG316591083',
CUSIP: NULL,
CIK: '1838821',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-02-26',
InternationalDomestic: NULL,
Sector: 'Financial Services',
Industry: 'Shell Companies',
HomeCategory: NULL,
IsDelisted: false,
}

ARYA Sciences Acquisition IV Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share -0.26
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get ARYA Sciences Acquisition IV Corp Earnings via APIs

  • Latest Release 2024-03-31
  • EPS/Forecast NaN

Get ARYA Sciences Acquisition IV Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get ARYA Sciences Acquisition IV Corp latest news via APIs

ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market Conditions

NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp IV (NASDAQ: ARYD) (“ARYA IV”), a publicly traded special purpose acquisition company sponsored by Perceptive Advisors a...
  • ARYA SCIENCES ACQUISITION CORP IV
  • BUSINESS CONTRACTS
  • NASDAQ:ARYD

ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market Conditions

NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp IV (NASDAQ: ARYD) (“ARYA IV”), a publicly traded special purpose acquisition company sponsored by Perceptive Advisors ann...
  • ADAM STONE
  • ARYA
  • ARYA IV
  • ARYA SCIENCES ACQUISITION CORP IV
  • BUSINESS COMBINATION
  • BUSINESS COMBINATION AGREEMENT
  • FORWARD-LOOKING STATEMENTS
  • MICHAEL ALTMAN
Do you have any questions?
support@eodhistoricaldata.com